Dr. Burns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8001 Frost St
Entrance 9
San Diego, CA 92123Phone+1 858-246-0155Fax+1 858-309-6301
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1983 - 1984
University of ColoradoFellowship, Infectious Disease, 1982 - 1983- University of ColoradoResidency, Pediatrics, 1978 - 1982
University of North Carolina at Chapel Hill School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1990 - 2025
WA State Medical License 1979 - 2014
CO State Medical License 1981 - 1983- American Board of Pediatrics Pediatrics
Clinical Trials
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Start of enrollment: 2009 Mar 01
- Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities Start of enrollment: 2012 Jul 01
- Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease Start of enrollment: 2014 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsSubgroups of children with Kawasaki disease: a data-driven cluster analysis.Hao Wang, Chisato Shimizu, Emelia Bainto, Shea Hamilton, Heather R Jackson
The Lancet. Child & Adolescent Health. 2023-10-01 - 5 citationsMIS-C: myths have been debunked, but mysteries remain.Jane C Burns
Nature Reviews. Rheumatology. 2023-02-01 - 1 citationsIncidence and Severity of Kawasaki Disease Among Vietnamese Children.Nguyen-Huong Doan, Nipha Sivilay, Chisato Shimizu, Hai Nguyen, Emelia Bainto
The Pediatric Infectious Disease Journal. 2022-11-01
Journal Articles
- Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2Adriana Tremoulet, Jane C Burns, JAMA
- Association of Initially Normal Coronary Arteries with Normal Findings on Follow-up Echocardiography in Patients with Kawasaki DiseaseDavid R Fulton, Adriana H Tremoulet, Jane C Burns, Jane W Newburger, Kevin G Friedman, JAMA
- Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression SignatureJohn T Kanegaye, Adriana H Tremoulet, Jane C Burns, Mary P Glode, JAMA
- Join now to see all
Authored Content
- Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2June 2020
Press Mentions
Diagnostic Tool Identifies Puzzling Inflammatory Diseases in KidsSeptember 9th, 2024- NIH Provides Research Grant for COVID-19 Detection TechnologyJanuary 11th, 2023
- Kawasaki Disease Declines During Pandemic, Offering Clues for PreventionJune 22nd, 2022
- Join now to see all
Grant Support
- Impact Of TNFA Blockade On Immune Function In Acute Kawasaki DiseaseNational Heart, Lung, And Blood Institute2010–2012
- Phase III Infliximab For Primary Treatment Of Kawasaki Disease IND 11046 6/27/200Food And Drug Administration2008–2011
- Genetic Markers And Gene Expression In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Genetic Influences And T-Cell Activation In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2008–2009
- Matrix Metalloproteinases In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2004–2008
- 8th International Kawasaki Disease SymposiumNational Heart, Lung, And Blood Institute2005
- Genetic Influences &Gene Expression In Kawasaki DiseaseNational Heart, Lung, And Blood Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
